Chao-Ming Lai
Nurse Practitioner · Houston, TXNPI 1265603252
Payments from drug & device makers
Across 150 payments — averaging $51.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$922
- Johnson & Johnson$857
- AbbVie$835
- Karyopharm Therapeutics Inc.$793
- AstraZeneca$726
- Incyte Corporation$716
- plus $3K from 18 others
What the payments were for
- Consulting fees$3254%
- Food & beverage$6,69186%
- Education$76710%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 11 | $922 |
| Johnson & Johnson | 16 | $857 |
| AbbVie | 10 | $835 |
| Karyopharm Therapeutics Inc. | 24 | $793 |
| AstraZeneca | 20 | $726 |
| Incyte Corporation | 11 | $716 |
| Amgen | 13 | $458 |
| ADC Therapeutics America, Inc. | 10 | $455 |
| Beigene USA, Inc. | 5 | $322 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $292 |
| Lilly USA, LLC | 7 | $262 |
| GSK | 4 | $216 |
| Vertex | 1 | $165 |
| Genentech USA, Inc. | 1 | $138 |
| Astellas Pharma US Inc | 2 | $120 |
| Regeneron | 2 | $116 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $114 |
| Gilead | 1 | $90 |
| Teleflex LLC | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Sobi, Inc | 1 | $34 |
| Morphosys, US Inc. | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Bristol Myers Squibb | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,783 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 15 | $60,482 |
| ValacyclovirValacyclovir Hcl | 77 | $2,055 |
| Pantoprazole Sodium | 17 | $233 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 34 | $170 |
| Ondansetron Hcl | 19 | $126 |
| Allopurinol | 12 | $35 |
| Prednisone | 17 | $34 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Houston
- Melanie MorrisHouston$254K
- Kelly BrassilHouston$194K
- Julie WeatherlyHouston$87K
- Katrina KingHouston$44K
- Allison TurnerHouston$37K
- Tiffany RichardsHouston$37K
- Bianca CaloHouston$36K
- Arby CohenHouston$23K
- Virginia MarxHouston$19K
- Hermeyone BellHouston$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.